Showing results (1231-1240 of 1,523) with videos related to

Sort By:
Pageof 153
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trialsMartin Schuler, Luis Paz-Ares, Lecia V Sequist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2023
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final AnalysisChong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2025
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA studyMarina Chiara Garassino, Yong He, Myung-Ju Ahn, et al.
Journal of Hematology & Oncology|January 5, 2025
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)Hua-Jun Chen, Hai-Yan Tu, Yanping Hu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 24, 2020
Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung CancerSachiko Arai, Shinji Takeuchi, Koji Fukuda, et al.
Thoracic Cancer|September 7, 2020
Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1<sup>+</sup> CD8<sup>+</sup> and CD8<sup>+</sup> T cells as predictive of response to neoadjuvant chemotherapy in breast cancerHongling Liang, Hongsheng Li, Zhi Xie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2018
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung CancerYi-Long Wu, Shun Lu, You Lu, et al.
Malaria Journal|September 20, 2019
Natural selection and genetic diversity of domain I of Plasmodium falciparum apical membrane antigen-1 on Bioko IslandYa-Nan Wang, Min Lin, Xue-Yan Liang, et al.
World Journal of Surgical Oncology|January 11, 2017
Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective studySong Dong, Ning Zhao, Wei Deng, et al.
Signal Transduction and Targeted Therapy|May 14, 2023
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancerJi Zhou, Xu-Chao Zhang, Shan Xue, et al.
Pageof 153